18/02/2015 - 17:34 MAUI, HAWAII – Though costly, newer biologics increase 1-year survival with metastatic melanoma from perhaps 40% to more than 70%. Among the latest... More » Visit websiteField of Interest: OncologyCategories: ONCR || VideoFPN || Video LibraryIMN || Video LibrarySAN || Video LibraryONCR || Melanoma & Skin CancersFPN || DermatologyFPN || OncologyNews Feed: Internal Medicine News - Oncology
